Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Spacer
Asston Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544445 INE0SJX01015 45.6540372 Not Listed 0 62.71 16.23 4.54 10
Your Result on : Markets | Equity | Corporate Information | Profit & Loss
     ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
INCOME :    
Sales Turnover 25.0416.036.549.60
Excise Duty0.000.000.000.00
Net Sales25.0416.036.549.60
Other Income 0.570.250.650.96
Stock Adjustments 0.000.000.000.00
Total Income25.6116.287.1910.56
EXPENDITURE :    
Raw Materials 14.149.752.686.70
Power & Fuel Cost0.140.010.000.00
Employee Cost 1.060.190.230.26
Other Manufacturing Expenses 0.210.120.670.98
Selling & Administrative Expenses 3.172.131.422.00
Miscellaneous Expenses 0.870.010.020.01
Less : Pre-operative Expenses Capitalised 0.000.000.000.00
Total Expenditure19.6012.205.029.95
Operating Profit6.014.072.170.60
Interest 0.950.760.720.43
Gross Profit5.063.311.450.17
Depreciation0.040.060.040.01
Profit Before Tax5.023.251.410.16
Tax1.220.810.340.03
Fringe Benefit tax0.000.000.000.00
Deferred Tax-0.060.010.020.02
Reported Net Profit3.852.431.060.11
Extraordinary Items 0.040.000.000.00
Adjusted Net Profit3.812.431.060.11
Adjustment below Net Profit -2.530.000.000.00
P & L Balance brought forward3.441.010.230.12
Statutory Appropriations0.000.000.000.00
Appropriations 0.000.000.000.00
P & L Balance carried down4.763.441.290.23
Dividend0.000.000.000.00
Preference Dividend0.000.000.000.00
Equity Dividend %0.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.00
Earnings Per Share-Unit Curr6.1431.0115.091.58
Earnings Per Share(Adj)-Unit Curr6.1431.0115.091.58
Book Value-Unit Curr17.6091.6328.3713.28
Book Value(Adj)-Unit Curr17.6091.6328.3713.28
Spacer